Skip to main content
. 2012 Jun 19;20(3):342–347. doi: 10.1007/s00534-012-0528-4

Table 2.

HCC recurrence characteristics

Time from transplant to recurrence (months ± SD) 24 ± 28
Patients alive with recurrence (%) 3 (10)
Time from recurrence to death (months ± SD) 33 ± 31
Location of recurrence
 Liver 14
 Lung 13
 Bone 7
 Other 4
Multiple locations (%) 8 (27)
Treatment of recurrence
 Medical/palliation 21 (70)
 Loco-regional (including TACE, PEI) 3 (10)
 Surgical resection 6 (20)

TACE transarterial chemo-embolisation, PEI percutaneous ethanol injection